Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01872078 · ClinicalTrials.gov registry record · Phase 2
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
A Phase 2 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 2
- Development phase
- 67
- Enrollment target
NCT01872078 is a Phase 2 study that has completed, run by AstraZeneca. The registered enrollment target is 67 participants.
The verdict
NCT01872078, a Phase 2 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 67 participants
- Enrollment target
Study Summary
To assess the effects of AZD4901 when given in multiple doses to females with Polycystic Ovary Syndrome
Interventions
- DRUG AZD4901 (oral)
- DRUG Placebo to match AZD4901
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01872078
The ClinicalTrials.gov registry entry for NCT01872078 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AZD4901 (oral) is the first listed.
NCT01872078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01872078 about?
NCT01872078 is a clinical study titled "A Study of AZD4901 in Females With Polycystic Ovary Syndrome". To assess the effects of AZD4901 when given in multiple doses to females with Polycystic Ovary Syndrome
What is the current status of trial NCT01872078?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 67 participants. The study started on 2013-06. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01872078?
The interventions under investigation include: AZD4901 (oral) (DRUG), Placebo to match AZD4901 (DRUG).
Who is sponsoring clinical trial NCT01872078?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.